Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02195713 · ClinicalTrials.gov registry record
Evaluation of a Novel Electronic Urine Output Monitor (eUOM)
A clinical trial, sponsored by Potrero Medical.
- Completed
- Registry status
- 20
- Enrollment target
NCT02195713: Completed study, sponsored by Potrero Medical.
NCT02195713 is a clinical trial that has completed, run by Potrero Medical. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02195713 has completed, sponsored by Potrero Medical.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
Urine output and urine drain line pressure were monitored while urine was drained into either: 1. Accuryn Urine Output Monitor (Potrero Medical) OR 2. Criticore Monitor (Bard Medical)
Primary Outcome
Urine output as recorded by the SOC when connected to a standard Foley catheter and standard urinary drainage tube will be compared to urine output recorded by Accuryn and the SOC when connected to a standard Foley catheter and the Accuryn Drainage Tube.
Interventions
- DEVICE Accuryn
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2014-07 |
| Est. Completion | 2015-02 |
What the finished NCT02195713 record still lists
NCT02195713 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Accuryn is the first listed.
NCT02195713 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02195713 about?
NCT02195713 is a clinical study titled "Evaluation of a Novel Electronic Urine Output Monitor (eUOM)". Urine output and urine drain line pressure were monitored while urine was drained into either: 1. Accuryn Urine Output Monitor (Potrero Medical) OR 2. Criticore Monitor (Bard Medical)
What is the current status of trial NCT02195713?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2014-07. Estimated completion is 2015-02.
What interventions are being tested in trial NCT02195713?
The interventions under investigation include: Accuryn (DEVICE).
Who is sponsoring clinical trial NCT02195713?
This trial is sponsored by Potrero Medical, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia